Financials

  • Market Capitalization 294.9 M
  • Employee 229
  • Founded 1999
  • CEO André Choulika
  • Website www.cellectis.com
  • Headquarter France
  • FIGI BBG0084L1XN2
  • Industry Technology
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты

Cellectis S.A. - American Depositary Shares

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Новости